GB0723512D0 - Genetic analysis systems and methods - Google Patents

Genetic analysis systems and methods

Info

Publication number
GB0723512D0
GB0723512D0 GBGB0723512.0A GB0723512A GB0723512D0 GB 0723512 D0 GB0723512 D0 GB 0723512D0 GB 0723512 A GB0723512 A GB 0723512A GB 0723512 D0 GB0723512 D0 GB 0723512D0
Authority
GB
United Kingdom
Prior art keywords
individual
disease
information
correlations
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0723512.0A
Other versions
GB2444410B (en
GB2444410A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FILIPPONE MELISSA F
Navigenics Inc
Original Assignee
FILIPPONE MELISSA F
Navigenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/781,679 external-priority patent/US20080131887A1/en
Application filed by FILIPPONE MELISSA F, Navigenics Inc filed Critical FILIPPONE MELISSA F
Publication of GB0723512D0 publication Critical patent/GB0723512D0/en
Publication of GB2444410A publication Critical patent/GB2444410A/en
Application granted granted Critical
Publication of GB2444410B publication Critical patent/GB2444410B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/30—Data warehousing; Computing architectures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G06F19/18—
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/10—Ploidy or copy number detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/40—Population genetics; Linkage disequilibrium
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Abstract

A method or system for assessing phenotypes, such as a disease or a susceptibility to a disease, of an individual's genomic information, such as single nucleotide polymorphisms (SNPs), comprises comparing a genomic profile of the individual with a database of genotype/phenotype correlations. reporting the results back to the individual, updating the database with newly discovered correlations and/or new genomic data and reporting the revised correlations back to the individual. Multiple genetic markers, together with other information, are combined to produce a Genetic Composite Index (GCI) score. An on-line portals comprising a website allows individuals to access and analyse the information. Methods for determining predisposition to, in particular, Alzheimer's Disease, colorectal cancer, osteoarthritis or exfoliation glaucoma, based on specific SNP markers, are provided.
GB0723512A 2006-11-30 2007-11-30 Genetic analysis systems and methods Active GB2444410B (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US86806606P 2006-11-30 2006-11-30
US95112307P 2007-07-20 2007-07-20
US11/781,679 US20080131887A1 (en) 2006-11-30 2007-07-23 Genetic Analysis Systems and Methods
US97219807P 2007-09-13 2007-09-13
US98562207P 2007-11-05 2007-11-05
US98968507P 2007-11-21 2007-11-21

Publications (3)

Publication Number Publication Date
GB0723512D0 true GB0723512D0 (en) 2008-01-09
GB2444410A GB2444410A (en) 2008-06-04
GB2444410B GB2444410B (en) 2011-08-24

Family

ID=38962435

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0723512A Active GB2444410B (en) 2006-11-30 2007-11-30 Genetic analysis systems and methods

Country Status (10)

Country Link
EP (1) EP2102651A4 (en)
JP (2) JP2010522537A (en)
KR (1) KR20090105921A (en)
CN (1) CN103642902B (en)
AU (1) AU2007325021B2 (en)
CA (1) CA2671267A1 (en)
GB (1) GB2444410B (en)
HK (1) HK1139737A1 (en)
TW (1) TWI363309B (en)
WO (1) WO2008067551A2 (en)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8340950B2 (en) 2006-02-10 2012-12-25 Affymetrix, Inc. Direct to consumer genotype-based products and services
US20080131887A1 (en) 2006-11-30 2008-06-05 Stephan Dietrich A Genetic Analysis Systems and Methods
WO2008103299A2 (en) 2007-02-16 2008-08-28 Massachusetts Eye & Ear Infirmary Methods and compositions for prognosing, detecting, and treating age-related macular degeneration
US20080228699A1 (en) 2007-03-16 2008-09-18 Expanse Networks, Inc. Creation of Attribute Combination Databases
FR2934698B1 (en) * 2008-08-01 2011-11-18 Commissariat Energie Atomique PREDICTION METHOD FOR THE PROGNOSIS OR DIAGNOSIS OR THERAPEUTIC RESPONSE OF A DISEASE AND IN PARTICULAR PROSTATE CANCER AND DEVICE FOR PERFORMING THE METHOD.
KR20110053995A (en) * 2008-08-08 2011-05-24 네이비제닉스 인크. Methods and systems for personalized action plans
AU2009291577A1 (en) * 2008-09-12 2010-03-18 Navigenics, Inc. Methods and systems for incorporating multiple environmental and genetic risk factors
NZ572036A (en) * 2008-10-15 2010-03-26 Nikola Kirilov Kasabov Data analysis and predictive systems and related methodologies
WO2010067381A1 (en) * 2008-12-12 2010-06-17 Decode Genetics Ehf Genetic variants as markers for use in diagnosis, prognosis and treatment of eosinophilia, asthma, and myocardial infarction
US8108406B2 (en) 2008-12-30 2012-01-31 Expanse Networks, Inc. Pangenetic web user behavior prediction system
EP3276526A1 (en) 2008-12-31 2018-01-31 23Andme, Inc. Finding relatives in a database
JP2012525147A (en) 2009-04-30 2012-10-22 グッド スタート ジェネティクス， インコーポレイテッド Methods and compositions for assessing genetic markers
MX2011012913A (en) * 2009-06-01 2012-02-21 Genetic Technologies Ltd Methods for breast cancer risk assessment.
DE102010013114B4 (en) * 2010-03-26 2012-02-16 Rüdiger Lawaczeck Prediagnostic safety system
KR20110136638A (en) * 2010-06-15 2011-12-21 재단법인 게놈연구재단 Online social network construction method and system with personal genome data
WO2012006669A1 (en) * 2010-07-13 2012-01-19 Fitgenes Pty Ltd System and method for determining personal health intervention
US20120078901A1 (en) * 2010-08-31 2012-03-29 Jorge Conde Personal Genome Indexer
WO2012054653A2 (en) 2010-10-19 2012-04-26 Medtronic, Inc. Diagnostic kits, genetic markers, and methods for scd or sca therapy selection
US20130226621A1 (en) * 2010-11-01 2013-08-29 Koninklijke Philips Electronics N.V. In vitro diagnostic testing including automated brokering of royalty payments for proprietary tests
US9163281B2 (en) 2010-12-23 2015-10-20 Good Start Genetics, Inc. Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction
US8718950B2 (en) 2011-07-08 2014-05-06 The Medical College Of Wisconsin, Inc. Methods and apparatus for identification of disease associated mutations
CA2812342C (en) * 2011-09-26 2015-04-07 John TRAKADIS Method and system for genetic trait search based on the phenotype and the genome of a human subject
US10378060B2 (en) 2011-10-14 2019-08-13 Dana-Farber Cancer Institute, Inc. ZNF365/ZFP365 biomarker predictive of anti-cancer response
KR101295785B1 (en) * 2011-10-31 2013-08-12 삼성에스디에스 주식회사 Apparatus and Method for Constructing Gene-Disease Relation Database
US10437858B2 (en) 2011-11-23 2019-10-08 23Andme, Inc. Database and data processing system for use with a network-based personal genetics services platform
US8209130B1 (en) 2012-04-04 2012-06-26 Good Start Genetics, Inc. Sequence assembly
KR20140009854A (en) * 2012-07-13 2014-01-23 삼성전자주식회사 Method and apparatus for analyzing gene information for treatment decision
KR101967248B1 (en) * 2012-08-16 2019-04-10 삼성전자주식회사 Method and apparatus for analyzing personalized multi-omics data
JP5844715B2 (en) * 2012-11-07 2016-01-20 学校法人沖縄科学技術大学院大学学園 Data communication system, data analysis apparatus, data communication method, and program
KR101533395B1 (en) * 2013-01-21 2015-07-08 이상열 Method and system estimating resemblance between subject using single nucleotide polymorphism
WO2014119914A1 (en) * 2013-02-01 2014-08-07 에스케이텔레콤 주식회사 Method for providing information about gene sequence-based personal marker and apparatus using same
US8778609B1 (en) 2013-03-14 2014-07-15 Good Start Genetics, Inc. Methods for analyzing nucleic acids
US20140274763A1 (en) * 2013-03-15 2014-09-18 Pathway Genomics Corporation Method and system to predict response to pain treatments
US9192647B2 (en) * 2013-10-04 2015-11-24 Hans-Michael Dosch Method for reversing recent-onset type 1 diabetes (T1D) by administering substance P (sP)
TW201516725A (en) * 2013-10-18 2015-05-01 Tci Gene Inc Single nucleotide polymorphism disease incidence prediction system
US10851414B2 (en) 2013-10-18 2020-12-01 Good Start Genetics, Inc. Methods for determining carrier status
FI20136079A (en) * 2013-11-04 2015-05-05 Medisapiens Oy Genetic health assessment procedure and system
DE202014010499U1 (en) 2013-12-17 2015-10-20 Kymab Limited Targeting of human PCSK9 for cholesterol treatment
KR101400946B1 (en) * 2013-12-27 2014-05-29 한국과학기술정보연구원 Biological network analyzing device and method thereof
KR102131973B1 (en) * 2013-12-30 2020-07-08 주식회사 케이티 Method and System for personalized healthcare
WO2015171370A1 (en) 2014-05-05 2015-11-12 Medtronic, Inc. Methods and compositions for scd, crt, crt-d, or sca therapy identification and/or selection
WO2015175530A1 (en) 2014-05-12 2015-11-19 Gore Athurva Methods for detecting aneuploidy
EP2975059A1 (en) 2014-07-15 2016-01-20 Kymab Limited Antibodies for use in treating conditions related to specific pcsk9 variants in specific patients populations
DE202015009007U1 (en) 2014-07-15 2016-08-19 Kymab Limited Targeting of human PCSK9 for cholesterol treatment
WO2016008899A1 (en) 2014-07-15 2016-01-21 Kymab Limited Targeting human pcsk9 for cholesterol treatment
WO2016023916A1 (en) 2014-08-12 2016-02-18 Kymab Limited Treatment of disease using ligand binding to targets of interest
WO2016035168A1 (en) * 2014-09-03 2016-03-10 大塚製薬株式会社 Pathology determination assistance device, method, program and storage medium
WO2016040446A1 (en) 2014-09-10 2016-03-17 Good Start Genetics, Inc. Methods for selectively suppressing non-target sequences
JP2017536087A (en) 2014-09-24 2017-12-07 グッド スタート ジェネティクス， インコーポレイテッド Process control to increase the robustness of genetic assays
WO2016071701A1 (en) 2014-11-07 2016-05-12 Kymab Limited Treatment of disease using ligand binding to targets of interest
WO2016112073A1 (en) 2015-01-06 2016-07-14 Good Start Genetics, Inc. Screening for structural variants
US11101038B2 (en) 2015-01-20 2021-08-24 Nantomics, Llc Systems and methods for response prediction to chemotherapy in high grade bladder cancer
CN107208156B (en) * 2015-02-09 2021-10-08 10X基因组学有限公司 System and method for determining structural variation and phasing using variation recognition data
US20180039731A1 (en) * 2015-03-03 2018-02-08 Nantomics, Llc Ensemble-Based Research Recommendation Systems And Methods
KR102508971B1 (en) * 2015-07-22 2023-03-09 주식회사 케이티 Method and apparatus for predicting the disease risk
CA3035342A1 (en) * 2015-09-16 2017-03-23 Good Start Genetics, Inc. Systems and methods for medical genetic testing
WO2017049214A1 (en) * 2015-09-18 2017-03-23 Omicia, Inc. Predicting disease burden from genome variants
KR101795662B1 (en) * 2015-11-19 2017-11-13 연세대학교 산학협력단 Apparatus and Method for Diagnosis of metabolic disease
FR3045874B1 (en) * 2015-12-18 2019-06-14 Axlr, Satt Du Languedoc Roussillon ARCHITECTURE FOR GENOMIC DATA ANALYSIS
JP6776576B2 (en) * 2016-03-28 2020-10-28 富士通株式会社 Database processing program, database processing device and database processing method
KR101991007B1 (en) * 2016-05-27 2019-06-20 (주)메디젠휴먼케어 A system and apparatus for disease-related genomic analysis using SNP
EP3479272A1 (en) * 2016-06-29 2019-05-08 Koninklijke Philips N.V. Disease-oriented genomic anonymization
KR101815529B1 (en) 2016-07-29 2018-01-30 (주)신테카바이오 Human Haplotyping System And Method
WO2018042185A1 (en) * 2016-09-02 2018-03-08 Imperial Innovations Ltd Methods, systems and apparatus for identifying pathogenic gene variants
CN106778083A (en) * 2016-11-28 2017-05-31 墨宝股份有限公司 A kind of method and device for automatically generating genetic test report
WO2018110490A1 (en) * 2016-12-12 2018-06-21 日本電気株式会社 Information processing device, genetic information creation method, and program
JP7264046B2 (en) * 2017-03-15 2023-04-25 東洋紡株式会社 Genetic test method and genetic test kit
CN108629153A (en) * 2017-03-23 2018-10-09 广州康昕瑞基因健康科技有限公司 Cma gene analysis method and system
EP3665483A4 (en) * 2017-08-08 2021-07-14 Queensland University of Technology Methods for diagnosis of early stage heart failure
KR102073590B1 (en) * 2017-08-17 2020-02-06 (주)에이엔티홀딩스 Method, system and non-transitory computer-readable recording medium for providing a service based on genetic information
KR102097540B1 (en) * 2017-12-26 2020-04-07 주식회사 클리노믹스 Method for disease and phenotype risk score calculation
CN108549795A (en) * 2018-03-13 2018-09-18 刘吟 Genetic counselling information system based on pedigree chart frame
GB201810897D0 (en) * 2018-07-03 2018-08-15 Chronomics Ltd Phenotype prediction
CN109355368A (en) * 2018-10-22 2019-02-19 江苏美因康生物科技有限公司 A kind of kit and method of quick detection hypertension individuation medication gene pleiomorphism
EP3874510A4 (en) 2018-10-31 2022-08-03 Ancestry.com DNA, LLC Estimation of phenotypes using dna, pedigree, and historical data
GB2578727A (en) * 2018-11-05 2020-05-27 Earlham Inst Genomic analysis
US20220073963A1 (en) * 2018-12-20 2022-03-10 The Johns Hopkins University Compositions and methods for detecting and treating type 1 diabetes and other autoimmune diseases
JP7137520B2 (en) * 2019-04-23 2022-09-14 ジェネシスヘルスケア株式会社 How to determine the risk of pancreatitis
JP7137521B2 (en) * 2019-04-24 2022-09-14 ジェネシスヘルスケア株式会社 How to determine your risk of psoriasis
JP7137523B2 (en) * 2019-04-24 2022-09-14 ジェネシスヘルスケア株式会社 How to determine your risk of hives
JP7137524B2 (en) * 2019-04-24 2022-09-14 ジェネシスヘルスケア株式会社 Methods for determining risk of knee osteoarthritis
JP7137525B2 (en) * 2019-04-24 2022-09-14 ジェネシスヘルスケア株式会社 How to determine the risk of contact dermatitis
JP7137526B2 (en) * 2019-04-24 2022-09-14 ジェネシスヘルスケア株式会社 Methods for determining the risk of atopic dermatitis
JP7137522B2 (en) * 2019-04-24 2022-09-14 ジェネシスヘルスケア株式会社 How to determine your scoliosis risk
KR102357453B1 (en) * 2019-06-24 2022-02-04 (주) 아이크로진 Service method and platform for visualizing using a gene information
KR102091790B1 (en) * 2019-09-02 2020-03-20 주식회사 클리노믹스 System for providng genetic zodiac sign using genetic information between examinees and organisms
KR102151716B1 (en) * 2019-12-06 2020-09-04 주식회사 클리노믹스 System for providing gemetic surmane information using genomic information
KR102179850B1 (en) * 2019-12-06 2020-11-17 주식회사 클리노믹스 System and method for predicting health using analysis device for intraoral microbes (bacteria, virus, viroid, and/or fungi)
KR102136207B1 (en) * 2019-12-31 2020-07-21 주식회사 클리노믹스 Sytem for providing personalized social contents imformation based on genetic information and method thereof
KR102138165B1 (en) * 2020-01-02 2020-07-27 주식회사 클리노믹스 Method for providing identity analyzing service using standard genome map database by nationality, ethnicity, and race
KR102223362B1 (en) * 2020-08-10 2021-03-05 주식회사 쓰리빌리언 System and method to identify disease associated genetic variants by using symptom associated genetic variants relationship
KR102223361B1 (en) * 2020-09-23 2021-03-05 주식회사 쓰리빌리언 System for diagnosing genetic disease using gene network
CN113921143B (en) * 2021-10-08 2024-04-16 天津金域医学检验实验室有限公司 Personalized estimation method and system for Bayes factors in coseparation analysis
CN114360732B (en) * 2022-01-12 2024-04-09 平安科技（深圳）有限公司 Medical data analysis method, device, electronic equipment and storage medium

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000067139A (en) * 1998-08-25 2000-03-03 Hitachi Ltd Electronic medical sheet system
WO2001016860A2 (en) * 1999-08-27 2001-03-08 Iris Bio Technologies, Inc. Artificial intelligence system for genetic analysis
WO2001026029A2 (en) * 1999-10-01 2001-04-12 Orchid Biosciences, Inc. Method and system for providing genotype clinical information over a computer network
US20030208454A1 (en) * 2000-03-16 2003-11-06 Rienhoff Hugh Y. Method and system for populating a database for further medical characterization
JP2002107366A (en) * 2000-10-02 2002-04-10 Hitachi Ltd Diagnosis-assisting system
WO2002063415A2 (en) * 2000-12-04 2002-08-15 Genaissance Pharmaceuticals, Inc. System and method for the management of genomic data
US20020128860A1 (en) * 2001-01-04 2002-09-12 Leveque Joseph A. Collecting and managing clinical information
US20020187483A1 (en) * 2001-04-20 2002-12-12 Cerner Corporation Computer system for providing information about the risk of an atypical clinical event based upon genetic information
US7461006B2 (en) * 2001-08-29 2008-12-02 Victor Gogolak Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data
WO2003039234A2 (en) * 2001-11-06 2003-05-15 David Pickar Pharmacogenomics-based system for clinical applications
US20040053263A1 (en) * 2002-08-30 2004-03-18 Abreu Maria T. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease
WO2004109551A1 (en) * 2003-06-05 2004-12-16 Hitachi High-Technologies Corporation Information providing system and program using base sequence related information
GB0313964D0 (en) * 2003-06-16 2003-07-23 Mars Inc Genotype test
US7084264B2 (en) * 2003-07-16 2006-08-01 Chau-Ting Yeh Viral sequences
US8222005B2 (en) * 2003-09-17 2012-07-17 Agency For Science, Technology And Research Method for gene identification signature (GIS) analysis
EP1684202A4 (en) * 2003-10-15 2007-10-03 Signpost Corp Method of determining genetic polymorphism for judgment of degree of disease risk, method of judging degree of disease risk, and judgment array
US20050209787A1 (en) * 2003-12-12 2005-09-22 Waggener Thomas B Sequencing data analysis
US7127355B2 (en) * 2004-03-05 2006-10-24 Perlegen Sciences, Inc. Methods for genetic analysis
EP1771575A1 (en) * 2004-07-16 2007-04-11 Bayer HealthCare AG Single nucleotide polymorphisms as prognostic tool to diagnose adverse drug reactions (adr) and drug efficacy
AU2005305765A1 (en) * 2004-11-19 2006-05-26 Oy Jurilab Ltd Method and kit for detecting a risk of essential arterial hypertension

Also Published As

Publication number Publication date
GB2444410B (en) 2011-08-24
KR20090105921A (en) 2009-10-07
JP2014140387A (en) 2014-08-07
TWI363309B (en) 2012-05-01
EP2102651A4 (en) 2010-11-17
EP2102651A2 (en) 2009-09-23
CN103642902A (en) 2014-03-19
WO2008067551A3 (en) 2008-12-11
AU2007325021A1 (en) 2008-06-05
JP2010522537A (en) 2010-07-08
TW200847056A (en) 2008-12-01
WO2008067551A2 (en) 2008-06-05
AU2007325021B2 (en) 2013-05-09
CN103642902B (en) 2016-01-20
HK1139737A1 (en) 2010-09-24
CA2671267A1 (en) 2008-06-05
GB2444410A (en) 2008-06-04

Similar Documents

Publication Publication Date Title
GB2444410B (en) Genetic analysis systems and methods
Chang et al. High density marker panels, SNPs prioritizing and accuracy of genomic selection
Barreiro et al. Natural selection has driven population differentiation in modern humans
Cooper et al. Systematic assessment of copy number variant detection via genome-wide SNP genotyping
Porras-Hurtado et al. An overview of STRUCTURE: applications, parameter settings, and supporting software
Mayer et al. Discovery of beneficial haplotypes for complex traits in maize landraces
Parchman et al. Genome‐wide association genetics of an adaptive trait in lodgepole pine
Voss‐Fels et al. Subgenomic diversity patterns caused by directional selection in bread wheat gene pools
Schmickl et al. Arabidopsis hybrid speciation processes
Folkersen et al. Impute. me: an open-source, non-profit tool for using data from direct-to-consumer genetic testing to calculate and interpret polygenic risk scores
Rohlfs et al. Familial identification: population structure and relationship distinguishability
Tassi et al. Early modern human dispersal from Africa: genomic evidence for multiple waves of migration
Yu et al. Single-molecule sequencing reveals a large population of long cell-free DNA molecules in maternal plasma
Dong et al. Genome-wide association study reveals both overlapping and independent genetic loci to control seed weight and silique length in Brassica napus
Palmer et al. A shared genetic basis of mimicry across swallowtail butterflies points to ancestral co-option of doublesex
Butcher et al. Generalist genes and cognitive neuroscience
Karafet et al. Extensive genome-wide autozygosity in the population isolates of Daghestan
Martin et al. Phylogeographic pattern of range expansion provides evidence for cryptic species lineages in Silene nutans in Western Europe
Aono et al. A joint learning approach for genomic prediction in polyploid grasses
Lindner et al. Performance of methods to detect genetic variants from bisulphite sequencing data in a non‐model species
Kivikoski et al. Predicting recombination frequency from map distance
Guitton et al. Ultra-deep whole genome bisulfite sequencing reveals a single methylation hotspot in human brain mitochondrial DNA
Adjaye Whole-genome approaches for large-scale gene identification and expression analysis in mammalian preimplantation embryos
Alexander et al. Limited movement of an avian hybrid zone in relation to regional variation in magnitude of climate change
Zhang et al. Genetic dissection of yield traits in super hybrid rice Xieyou9308 using both unconditional and conditional genome-wide association mapping

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application